Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yawen Li & Huaiyu Zhou. (2018) Moving towards improved vaccines for Toxoplasma gondii. Expert Opinion on Biological Therapy 18:3, pages 273-280.
Read now
Read now
Marie-Thérèse Labro. (2012) Immunomodulatory effects of antimicrobial agents. Part II: antiparasitic and antifungal agents. Expert Review of Anti-infective Therapy 10:3, pages 341-357.
Read now
Read now
Articles from other publishers (18)
Wahida Rahaman & Arabinda Chaudhuri. (2023) RGDK-lipopeptide for targeting genetic vaccines to antigen presenting cells. Biomedical Materials 19:1, pages 015004.
Crossref
Crossref
Tooran Nayeri, Shahabeddin Sarvi, Mahdi Fasihi-Ramandi, Reza Valadan, Hossein Asgarian-Omran, Abolghasem Ajami, Alireza khalilian, Zahra Hosseininejad, Samira Dodangeh, Javad Javidnia & Ahmad Daryani. (2023) Enhancement of immune responses by vaccine potential of three antigens, including ROP18, MIC4, and SAG1 against acute toxoplasmosis in mice. Experimental Parasitology 244, pages 108427.
Crossref
Crossref
Fetene Mihretu, Gebeyehu Tsega, Melesse Belayneh & Mesafint Molla Adane. (2022) Risk Factors of Noncompliance to Preventive Mass Drug Administration for Eliminating Lymphatic Filariasis: A Case-Control Study in Jawi District, Northwest Ethiopia. Journal of Tropical Medicine 2022, pages 1-9.
Crossref
Crossref
Suraj kumar Sharma, Shivani Srivastava, Ajay Kumar & Vivek Srivastava. (2021) Anticipation of Antigenic Sites for the Goal of Vaccine Designing Against Nipah Virus: An Immunoinformatics Inquisitive Quest. International Journal of Peptide Research and Therapeutics 27:3, pages 1899-1911.
Crossref
Crossref
Leonardo A. Gómez & Angel A. Oñate. 2019. Plasmid. Plasmid.
Eric Farris, Deborah M Brown, Amanda E Ramer-Tait & Angela K Pannier. (2016) Micro- and nanoparticulates for DNA vaccine delivery. Experimental Biology and Medicine 241:9, pages 919-929.
Crossref
Crossref
O Riede, K Seifert, D Oswald, A Endmann, C Hock, A Winkler, F J Salguero, M Schroff, S L Croft & C Juhls. (2015) Preclinical safety and tolerability of a repeatedly administered human leishmaniasis DNA vaccine. Gene Therapy 22:8, pages 628-635.
Crossref
Crossref
Milena Sobral Espíndola, Fabiani Gai Frantz, Luana Silva Soares, Ana Paula Masson, Cristiane Tefé-Silva, Claudia Silva Bitencourt, Sérgio Costa Oliveira, Vanderlei Rodrigues, Simone Gusmão Ramos, Célio Lopes Silva & Lúcia Helena Faccioli. (2014) Combined immunization using DNA-Sm14 and DNA-Hsp65 increases CD8+ memory T cells, reduces chronic pathology and decreases egg viability during Schistosoma mansoniinfection. BMC Infectious Diseases 14:1.
Crossref
Crossref
A.K. Singh, A.K. Verma, Neha .Ruchi Tiwari .K. Karthik .Kuldeep Dhama .S.V. Singh .. (2014) Trends and Advances in Vaccines Against Protozoan Parasites of Veterinary Importance: A Review. Journal of Biological Sciences 14:2, pages 95-109.
Crossref
Crossref
N. Saljoughian, F. Zahedifard, D. Doroud, F. Doustdari, M. Vasei, B. Papadopoulou & S. Rafati. (2013) Cationic solid-lipid nanoparticles are as efficient as electroporation in DNA vaccination against visceral leishmaniasis in mice. Parasite Immunology 35:12, pages 397-408.
Crossref
Crossref
Louise von Gersdorff Jørgensen, Jens Sigh, Per Walter Kania, Lars Holten-Andersen, Kurt Buchmann, Theodore Clark, Jesper Skou Rasmussen, Katja Einer-Jensen & Niels Lorenzen. (2012) Approaches towards DNA Vaccination against a Skin Ciliate Parasite in Fish. PLoS ONE 7:11, pages e48129.
Crossref
Crossref
Christopher Schliehe, Annegret Bitzer, Maries van den Broek & Marcus Groettrup. (2012)
Stable Antigen Is Most Effective for Eliciting CD8
+
T-Cell Responses after DNA Vaccination and Infection with Recombinant Vaccinia Virus
In Vivo
. Journal of Virology 86:18, pages 9782-9793.
Crossref
Crossref
Alan Gunn & Sarah J. Pitt. 2012. Parasitology. Parasitology
375
429
.
Delaram Doroud, Farnaz Zahedifard, Alireza Vatanara, Yasaman Taslimi, Rouholah Vahabpour, Fatemeh Torkashvand, Behrooz Vaziri, Abdolhossein Rouholamini Najafabadi & Sima Rafati. (2011) C-Terminal Domain Deletion Enhances the Protective Activity of cpa/cpb Loaded Solid Lipid Nanoparticles against Leishmania major in BALB/c Mice. PLoS Neglected Tropical Diseases 5:7, pages e1236.
Crossref
Crossref
Bashir Akhlaq Akhoon, Parvez Singh Slathia, Preeti Sharma, Shishir Kumar Gupta & Vijeshwar Verma. (2011) In silico identification of novel protective VSG antigens expressed by Trypanosoma brucei and an effort for designing a highly immunogenic DNA vaccine using IL-12 as adjuvant. Microbial Pathogenesis 51:1-2, pages 77-87.
Crossref
Crossref
Delaram Doroud, Farnaz Zahedifard, Alireza Vatanara, Abdolhossein Rouholamini Najafabadi, Yasaman Taslimi, Rouholah Vahabpour, Fatemeh Torkashvand, Behrooz Vaziri & Sima Rafati. (2011) Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection. Journal of Controlled Release 153:2, pages 154-162.
Crossref
Crossref
Andreia Sofia Cruz Lança, Karina Pires de Sousa, Jorge Atouguia, Duarte Miguel F. Prazeres, Gabriel Amaro Monteiro & Marcelo Sousa Silva. (2011) Trypanosoma brucei: Immunisation with plasmid DNA encoding invariant surface glycoprotein gene is able to induce partial protection in experimental African trypanosomiasis. Experimental Parasitology 127:1, pages 18-24.
Crossref
Crossref
Nyamongo Onkoba, Ruth Mumo, Josiah Ogise, Hastings Ozwara & Thomas Egwang. (2021) Cross-Species Inhibitory Antibody Responses in Mice Vaccinated with Plasmid DNA Encoding Polypeptides of <i>Plasmodium Falciparum</i> SERA-5, Microbial Epitopes and a Chemokine. SSRN Electronic Journal.
Crossref
Crossref